Tarsus Pharmaceuticals Newsroom

A Quick Look at Today's Ratings for Tarsus Pharmaceuticals(TARS.US), With a Forecast Between $65 to $84

Moomoo NewsNov 15 08:03 ET

Tarsus Pharmaceuticals Is Maintained at Neutral by Goldman Sachs

Dow JonesNov 15 06:57 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaNov 14 08:17 ET

Barclays Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsNov 14 05:32 ET

Barclays Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsNov 13 05:38 ET

Barclays Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsOct 28 05:34 ET

Oppenheimer Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $63

Moomoo NewsOct 22 08:34 ET

Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Neurocrine (NBIX) and Tarsus Pharmaceuticals (TARS)

TipRanksOct 22 08:04 ET

LifeSci Capital Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $67

Moomoo NewsOct 17 08:31 ET

Guggenheim Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating

Moomoo NewsOct 11 16:32 ET

Guggenheim Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating

Moomoo NewsOct 4 16:32 ET

Oppenheimer Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $63

Moomoo NewsSep 27 08:33 ET

Oppenheimer Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $63

Moomoo NewsSep 23 08:33 ET

Barclays Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsAug 13 05:32 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaAug 9 11:27 ET

Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $63 From $61, Maintains Outperform Rating

MT NewswiresAug 9 09:00 ET

LifeSci Capital Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $67

Moomoo NewsAug 2 13:31 ET

Oppenheimer Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $61

Moomoo NewsJul 29 08:33 ET

Analysts' Top Healthcare Picks: Chromadex (CDXC), Tarsus Pharmaceuticals (TARS)

TipRanksJul 29 08:05 ET

Barclays Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsJul 25 05:34 ET